JP EQUITY · SINGLE-STOCK DEEP DIVE · 出光興産

이데미쓰(出光興産) — 정유 — 2019 쇼와셸 통합Idemitsu Kosan (出光興産) — Refining — merged with Showa Shell 2019出光興産 — 石油精製 — 2019年に昭和シェルと統合

EDINET 有価証券報告書 FY2015~FY2025 를 이어 붙인 공통 재무 점검. 매출 35,702 → 81,059억엔, 영업이익률 -0.5% → 2.6%, ROIC -1.3% → 6.1%. 정유사는 이익의 큰 몫이 재고평가(유가 방향)에서 온다 — 그 몫을 먼저 걷어 내고 본다(②). 손익 엔진·현금·운전자본·자본 배분·장부 점검·밸류에이션, 그리고 이 주가가 이익(P/E)을 따라가는지 장부(P/B)에 묶였는지를 같은 틀로 잰다. 방향은 단정하지 않는다.A common financial check built by linking EDINET annual securities reports for FY2015~FY2025. Revenue 35,702 → 81,059 JPY 100mn, operating margin -0.5% → 2.6%, ROIC -1.3% → 6.1%. For refiners a large share of profit comes from inventory valuation (the direction of oil prices) — that share is stripped out first (②). The profit engine, cash, working capital, capital allocation, accounting checks and valuation — and whether this share price tracks earnings (P/E) or is anchored to book value (P/B) — are measured with the same frame. No view on direction is taken.EDINETの有価証券報告書FY2015~FY2025をつなぎ合わせた共通の財務点検。売上高35,702 → 81,059億円、 営業利益率-0.5% → 2.6%、ROIC -1.3% → 6.1%。 石油元売りは利益の大きな部分が在庫評価(原油価格の方向)から来る — その分をまず取り除いて見る(②)。 損益エンジン・現金・運転資本・資本配分・帳簿点検・バリュエーション、そしてこの株価が利益(P/E)に連動するのか簿価(P/B)に縛られているのかを同じ枠組みで測る。方向は断定しない。

FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). 회계기준 Japan GAAP. 기말 주가·시가총액·P/B 는 그해 有報의 EPS × PER 로 역산한 가공값(적자 해는 PER 미기재로 빈칸). 분기보고서는 2024년 4월 폐지 — 그 뒤는 반기뿐이다(마지막 반기 2025 H2 · 2026-03-31).FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). Accounting standard: Japan GAAP. Year-end share prices, market cap and P/B are derived values back-calculated as EPS × P/E from that year’s annual securities report (loss years are blank because P/E is not reported). Quarterly securities reports were abolished in April 2024 — after that there are only half-year figures (last half 2025 H2 · 2026-03-31).FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). 会計基準日本基準。 期末株価・時価総額・P/Bはその年の有報のEPS × PERから逆算した加工値(赤字の年はPER記載なしのため空欄)。 四半期報告書は2024年4月に廃止 — それ以降は半期のみ(直近の半期2025 H2 · 2026-03-31)。
매출 FY2025Revenue FY2025売上高 FY202581,059억엔81,059 JPY 100mn81,059億円FY2015 35,702억엔FY2015 35,702 JPY 100mnFY2015 35,702億円
영업이익률Operating margin営業利益率2.6%FY2015 -0.5%
ROIC(영업 투하자본)ROIC (operating invested capital)ROIC(営業投下資本)6.1%고점 FY2021 14.1%Peak FY2021 14.1%ピーク FY2021 14.1%
안전마진Margin of safety安全余裕率24.9%영업 레버리지 4.01배Operating leverage 4.01x営業レバレッジ4.01倍
누적 FCFCumulative FCF累計FCF10,105억엔10,105 JPY 100mn10,105億円FY2015~FY2025
P/B (가공)P/B (derived)P/B(加工値)0.98배0.98x0.98倍범위 0.53~1.06Range 0.53~1.06範囲0.53~1.06
P/E11.0배11.0x11.0倍배당수익률 2.33%Dividend yield 2.33%配当利回り2.33%
P/E 냐 P/B 냐P/E or P/BP/EかP/Bかβ 0.14장부에 묶임Anchored to book簿価に縛られる

① 손익 패널Income statement panel損益パネル — FY2015~FY2025

억엔 · 비율 = 매출 대비 % · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025).JPY 100mn · ratios = % of revenue · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025).億円 · 比率 = 売上高比% · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). · Data as of 2026-03-31 · Created 2026-11-01
FY매출Revenue売上高매출총이익률Gross margin売上総利益率판관비율SG&A ratio販管費率연구개발/매출R&D/revenue研究開発費/売上高영업이익Operating profit営業利益영업이익률Operating margin営業利益率경상이익Ordinary profit経常利益특별손익Extraordinary items特別損益순이익Net profit純利益특별 제외 순이익Net profit ex. extraordinary items特別損益除く純利益ROE
201535,7027.3%7.9% 0.4%-196-0.5%-219 -331-360 -141-7.2%
201631,90313.2%8.9% 0.4%1,3524.2%1,400 -170882 1,00616.3%
201737,30713.2%7.8% 0.4%2,0135.4%2,263 -1421,623 1,73422.4%
201844,25111.0%7.0% 0.4%1,7934.0%1,691 -244815 9619.5%
201960,4596.8%6.9% 0.3%-39-0.1%-140 -33-229 -207-2.3%
202045,56612.3%9.2% 0.4%1,4013.1%1,084 -438349 5883.0%
202166,86813.2%6.7% 0.4%4,3456.5%4,593 -7122,795 3,30321.8%
202294,5638.4%5.4% 0.3%2,8243.0%3,215 2672,536 2,34416.8%
202387,1929.7%5.7% 0.3%3,4634.0%3,852 -5852,285 2,69113.4%
202491,9027.5%5.7% 0.4%1,6221.8%2,148 -5641,041 1,4045.9%
202581,0599.3%6.7% 0.4%2,1222.6%2,296 -751,719 1,7759.4%
반기Half半期매출Revenue売上高매출총이익률Gross margin売上総利益率판관비SG&A販管費영업이익Operating profit営業利益영업이익률Operating margin営業利益率경상이익Ordinary profit経常利益순이익Net profit純利益
2024 H145,040 — —973 2.2% 1,249994
2024 H246,862 — —649 1.4% 89946
2025 H138,057 — —258 0.7% 353361
2025 H243,002 — —1,864 4.3% 1,9441,358
매출은 FY2015 35,702억엔에서 FY2025 81,059억엔(연 8.6%), 영업이익률은 -0.5% → 2.6%. 특별 제외 순이익 = 순이익 − 특별손익 × (1 − 그해 실효세율). 2024-04 四半期報告書 폐지로 2024년 하반기부터는 반기만 있다 — 최근 반기 2025 H2 영업이익 1,864억엔(전년 같은 반기 649억엔).Revenue went from 35,702 JPY 100mn in FY2015 to 81,059 JPY 100mn in FY2025 (8.6% a year); operating margin -0.5% → 2.6%. Net profit ex. extraordinary items = net profit − extraordinary items × (1 − that year's effective tax rate). With quarterly securities reports abolished in April 2024, only half-year figures exist from the second half of 2024 — latest half 2025 H2: operating profit 1,864 JPY 100mn (same half a year earlier 649 JPY 100mn).売上高はFY2015の35,702億円からFY2025の81,059億円(年率8.6%)、営業利益率は-0.5% → 2.6%。 特別損益除く純利益 = 純利益 − 特別損益 ×(1 − その年の実効税率)。2024年4月の四半期報告書廃止により、2024年下期からは半期のみ — 直近の半期2025 H2の営業利益1,864億円(前年同半期649億円)。

② 재고평가 효과 — 이익 중 유가가 만든 몫Inventory valuation effect — the share of profit made by oil prices在庫評価影響 — 利益のうち原油価格がもたらした分

억엔JPY 100mn億円 · Data as of 2026-03-31 · Created 2026-11-01
FY기준 이익Profit measure基準利益보고 이익Reported profit報告利益재고평가 효과Inventory valuation effect在庫評価影響효과 제외 이익Profit ex. effect影響除く利益|효과| ÷ 보고 이익|Effect| ÷ reported profit|影響| ÷ 報告利益
2016営業利益Operating profit営業利益1,352 3311,021 24%
2017営業利益Operating profit営業利益2,013 3111,702 15%
2018営業利益Operating profit営業利益1,793 601,733 3%
2019セグメント利益Segment profitセグメント利益-262 -893631 341%
2020セグメント利益Segment profitセグメント利益1,003 75928 7%
2021セグメント利益Segment profitセグメント利益4,495 2,3322,162 52%
2022セグメント利益Segment profitセグメント利益3,084 5572,527 18%
2023セグメント利益Segment profitセグメント利益3,630 5243,106 14%
2024セグメント利益Segment profitセグメント利益1,848 -2992,147 16%
2025セグメント利益Segment profitセグメント利益2,147 -2942,441 14%
재고평가 효과 누계 2,704억엔 · 보고 이익 대비 |효과| 중앙값 16% · 가장 큰 해 FY2021 2,332억엔. 재고평가 효과 + = 유가 상승기 원가 押し下げ(이익 증가), − = 하락기 押し上げ. 기준 이익은 회사가 MD&A·결산 설명에서 쓴 것 그대로. 손익 엔진·ROIC 는 보고 이익 그대로라 이 효과가 섞여 있다.Cumulative inventory valuation effect 2,704 JPY 100mn · median |effect| relative to reported profit 16% · largest year FY2021 2,332 JPY 100mn. 재고평가 효과 + = 유가 상승기 원가 押し下げ(이익 증가), − = 하락기 押し上げ. 기준 이익은 회사가 MD&A·결산 설명에서 쓴 것 그대로. The profit engine and ROIC use reported profit as is, so this effect is mixed in.在庫評価影響の累計2,704億円 · 報告利益に対する|影響|の中央値16% · 最大の年FY2021 2,332億円。재고평가 효과 + = 유가 상승기 원가 押し下げ(이익 증가), − = 하락기 押し上げ. 기준 이익은 회사가 MD&A·결산 설명에서 쓴 것 그대로. 損益エンジン・ROICは報告利益のままのため、この影響が混じっている。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 회사가 MD&A·결산 설명에 밝힌 재고평가 영향을 옮겼다 — 회사마다 기준 이익(営業利益·セグメント利益·経常利益)이 다르고, 영향을 밝히지 않은 해는 빠진다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Inventory valuation effects as disclosed by the company in its MD&A and results briefings — the profit measure differs by company (operating profit, segment profit, ordinary profit), and years in which the effect was not disclosed are omitted.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 会社がMD&A・決算説明で開示した在庫評価影響を転記した — 基準とする利益(営業利益・セグメント利益・経常利益)は会社ごとに異なり、影響を開示していない年は含まない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

③ 비용 구조 — 매출 1엔이 어디로 가나Cost structure — where each yen of revenue goesコスト構造 — 売上1円はどこへ行くか

매출 대비 %% of revenue売上高比% · Data as of 2026-03-31 · Created 2026-11-01
매출원가율 FY2015 92.7% → FY2025 90.7% · 판관비율 7.9% → 6.7% · 연구개발/매출 0.4% → 0.4% · 감가상각/매출 2.3% → 1.2%. 판관비는 손익계산서 합계(판매비·일반관리비 구분 없음), 연구개발비는 주석의 총액(판관비 안 포함분), 감가상각은 현금흐름표 합계라 다른 선과 겹친다 — 더하면 안 된다.Cost-of-sales ratio FY2015 92.7% → FY2025 90.7% · SG&A ratio 7.9% → 6.7% · R&D/revenue 0.4% → 0.4% · depreciation/revenue 2.3% → 1.2%. SG&A is the income-statement total (no split between selling and G&A expenses); R&D is the total from the notes (including the part within SG&A) and depreciation is the cash-flow-statement total, so they overlap with the other lines — do not add them up.売上原価率FY2015 92.7% → FY2025 90.7% · 販管費率7.9% → 6.7% · 研究開発費/売上高0.4% → 0.4% · 減価償却費/売上高2.3% → 1.2%。 販管費は損益計算書の合計(販売費・一般管理費の区分なし)、研究開発費は注記の総額(販管費に含まれる分を含む)、減価償却費はキャッシュ・フロー計算書の合計のため、他の線と重複する — 足し合わせてはならない。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 판관비 구분·연구개발비·감가상각은 원문 계정 그대로라 서로 겹친다(연구개발비는 판관비·제조원가 안에, 감가상각은 현금흐름표 합계) — 더하면 안 된다. 세로축은 로그 눈금.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: The SG&A breakdown, R&D and depreciation follow the original accounts and overlap (R&D sits inside SG&A and manufacturing cost; depreciation is the cash-flow-statement total) — do not add them up. The vertical axis is on a log scale.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 販管費の内訳・研究開発費・減価償却費は原文の勘定科目のままで互いに重複する(研究開発費は販管費・製造原価の中、減価償却費はキャッシュ・フロー計算書の合計)— 足し合わせてはならない。縦軸は対数目盛。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

④ 손익 엔진 — 고정비가 얼마나 무거워졌나Profit engine — how much heavier fixed costs have become損益エンジン — 固定費はどれだけ重くなったか

억엔 · % · 계정 분류(勘定科目法)JPY 100mn · % · account-classification method億円 · % · 勘定科目法 · Data as of 2026-03-31 · Created 2026-11-01
안전마진 — 매출이 몇 % 빠지면 영업적자인가Margin of safety — how far revenue can fall (%) before an operating loss安全余裕率 — 売上が何%減ると営業赤字か
FY2015-5.8%
FY202524.9%
손익분기 매출 37,757 → 60,833억엔Break-even revenue 37,757 → 60,833 JPY 100mn損益分岐点売上高37,757 → 60,833億円
고정비(판관비 + 감가상각)Fixed costs (SG&A + depreciation)固定費(販管費 + 減価償却費)
FY20153,610억엔3,610 JPY 100mn3,610億円
FY20256,382억엔6,382 JPY 100mn6,382億円
공헌이익률 9.6% → 10.5%Contribution margin 9.6% → 10.5%限界利益率9.6% → 10.5%
영업 레버리지 — 매출 1% 변화 → 영업이익 몇 %Operating leverage — % change in operating profit per 1% change in revenue営業レバレッジ — 売上1%の変化 → 営業利益は何%
FY2015-17.38배-17.38x-17.38倍
FY20254.01배4.01x4.01倍
공헌이익 ÷ 영업이익Contribution ÷ operating profit限界利益 ÷ 営業利益
변동비율 여유 — 원가율이 몇 %p 오르면 적자인가Variable-cost headroom — how many pp the cost ratio can rise before a loss変動費率の余裕 — 原価率が何%pt上がると赤字か
FY20252.6%p2.6pp2.6%pt
= 영업이익률. 원료가가 판가보다 이만큼 더 오르면 고정비를 못 덮는다.= operating margin. If raw-material prices rise this much more than selling prices, fixed costs are no longer covered.= 営業利益率。原料価格が販売価格よりこれだけ多く上がると、固定費を賄えない。
FY매출Revenue売上高변동비Variable costs変動費고정비Fixed costs固定費공헌이익률Contribution margin限界利益率손익분기 매출Break-even revenue損益分岐点売上高안전마진Margin of safety安全余裕率영업 레버리지Operating leverage営業レバレッジ
201535,70232,2893,610 9.6%37,757-5.8%-17.38
201631,90327,0073,545 15.3%23,09327.6%3.62
201737,30731,6893,605 15.1%23,93835.8%2.79
201844,25138,7583,700 12.4%29,80632.6%3.06
201960,45955,3775,120 8.4%60,918-0.8%-131.64
202045,56638,9945,171 14.4%35,85521.3%4.69
202166,86856,9785,545 14.8%37,49243.9%2.28
202294,56385,5786,160 9.5%64,83631.4%3.18
202387,19277,7296,000 10.8%55,28236.6%2.73
202491,90284,0526,229 8.5%72,91620.7%4.84
202581,05972,5546,382 10.5%60,83324.9%4.01
회귀로는 못 잰다Not measurable by regression回帰では測れない 분기 비용(매출 − 영업이익)을 매출에 회귀하면 기울기 0.97(±0.02, R² 0.99, 2016Q1~2023Q4 32분기) · 절편(분기 고정비) -40억엔. 비용이 매출과 거의 1:1 로 움직여(판가가 원료에 연동) 고정비가 통계적으로 잡히지 않는다 — 그래서 계정 분류로 나눴다.Regressing quarterly costs (revenue − operating profit) on revenue gives a slope of 0.97 (±0.02, R² 0.99, 2016Q1~2023Q4, 32 quarters) · intercept (quarterly fixed costs) -40 JPY 100mn. Costs move almost 1:1 with revenue (selling prices are linked to raw materials), so fixed costs cannot be identified statistically — hence the split by account.四半期コスト(売上高 − 営業利益)を売上高に回帰すると傾き0.97(±0.02、R² 0.99、2016Q1~2023Q4、32四半期)· 切片(四半期の固定費)-40億円。 コストが売上高とほぼ1:1で動く(販売価格が原料に連動)ため、固定費が統計的に捉えられない — そこで勘定科目で分けた。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 고정비·변동비는 계정으로 나눈 근사이지 회사가 공시한 원가 구조가 아니다 — 매출원가 안 인건비는 변동으로, 판관비 안 운임은 고정으로 들어간다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Fixed and variable costs are an approximation split by account, not a cost structure disclosed by the company — labour costs within cost of sales count as variable and freight within SG&A as fixed.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 固定費・変動費は勘定科目で分けた近似であり、会社が開示した原価構造ではない — 売上原価中の人件費は変動費に、販管費中の運賃は固定費に入る。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑤ 발생액 — 순이익 vs 영업현금흐름Accruals — net profit vs operating cash flow発生高 — 純利益 vs 営業キャッシュ・フロー

억엔JPY 100mn億円 · Data as of 2026-03-31 · Created 2026-11-01
발생액/총자산 3년 평균Accruals/total assets, 3-year average発生高/総資産 3年平均-5.0%
순이익 > 영업현금흐름인 해Years with net profit > operating cash flow純利益 > 営業キャッシュ・フローの年5 / 11년5 / 11 years5 / 11年
누적 영업현금흐름Cumulative operating cash flow累計営業キャッシュ・フロー20,553억엔20,553 JPY 100mn20,553億円
누적 순이익Cumulative net profit累計純利益13,455억엔13,455 JPY 100mn13,455億円
발생액 = 순이익 − 영업현금흐름. 음수면 현금이 이익보다 많이 들어왔다(감가상각이 큰 장치산업의 정상 모습). 크게 양수로 돌면 이익의 질을 의심한다.Accruals = net profit − operating cash flow. A negative value means more cash came in than profit (normal for capital-intensive industries with heavy depreciation). A large swing to positive casts doubt on earnings quality.発生高 = 純利益 − 営業キャッシュ・フロー。マイナスなら利益より多くの現金が入った(減価償却の大きい装置産業では正常な姿)。大きくプラスに転じたら利益の質を疑う。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 연결 연간 값. 영업현금흐름엔 운전자본 변동이 들어 있어 원료 시차가 큰 해에 크게 흔들린다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Consolidated annual figures. Operating cash flow includes working-capital changes, so it swings widely in years with large raw-material time lags.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 連結の年次値。営業キャッシュ・フローには運転資本の増減が含まれるため、原料のタイムラグが大きい年は大きく振れる。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑥ CAPEX · FCF — 번 돈과 넣은 돈Capex · FCF — money earned and money investedCAPEX · FCF — 稼いだお金と投じたお金

억엔JPY 100mn億円 · Data as of 2026-03-31 · Created 2026-11-01
누적 설비투자 ÷ 누적 감가상각Cumulative capex ÷ cumulative depreciation累計設備投資 ÷ 累計減価償却費1.07배1.07x1.07倍
최근 3년 설비투자 ÷ 감가상각Capex ÷ depreciation, last 3 years直近3年の設備投資 ÷ 減価償却費1.17배1.17x1.17倍
누적 FCFCumulative FCF累計FCF10,105억엔10,105 JPY 100mn10,105億円
FCF 적자 연도Years with negative FCFFCFマイナスの年2019 · 2022
FCF 수익률 FY2025FCF yield FY2025FCF利回り FY202512.0%
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 설비투자는 유·무형자산 취득 현금만 — 리스로 들인 자산과 기업 인수는 빠진다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Capex covers only cash paid to acquire property, plant and equipment and intangible assets — leased assets and acquisitions are excluded.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 設備投資は有形・無形固定資産の取得による支出のみ — リースで取得した資産と企業買収は含まない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑦ 운전자본 — 매출채권 · 재고 · 매입채무 회전Working capital — receivables · inventory · payables turnover運転資本 — 売上債権・棚卸資産・仕入債務の回転

일 · 기말 잔액 기준Days · year-end balances日 · 期末残高ベース · Data as of 2026-03-31 · Created 2026-11-01
현금 전환 주기(CCC = DSO + DIO − DPO)는 FY2015 34일 → FY2025 64일 (매출채권 27 → 38일 · 재고 40 → 68일 · 매입채무 32 → 42일). 늘어난 30일을 FY2025 매출로 환산하면 약 6,551억엔이 운전자본에 더 묶여 있다. 매출채권은 전자기록채권 포함. 재고는 매출원가 기준.The cash conversion cycle (CCC = DSO + DIO − DPO) went from 34 days in FY2015 to 64 days in FY2025 (receivables 27 → 38 days · inventory 40 → 68 days · payables 32 → 42 days). Converting the 30 additional days at FY2025 revenue, about 6,551 JPY 100mn more is tied up in working capital. Receivables include electronically recorded monetary claims. Inventory is measured against cost of sales.キャッシュ・コンバージョン・サイクル(CCC = DSO + DIO − DPO)はFY2015の34日 → FY2025の64日 (売上債権27 → 38日 · 棚卸資産40 → 68日 · 仕入債務32 → 42日)。 増えた30日をFY2025の売上高で換算すると、約6,551億円が運転資本に余分に拘束されている。 売上債権は電子記録債権を含む。棚卸資産は売上原価ベース。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 기말 잔액 기준이라 결산일 계절성이 섞인다. 매출채권은 전자기록채권을 포함(공시된 해)하고, 재고·매입채무는 매출원가 기준.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Based on year-end balances, so balance-sheet-date seasonality is mixed in. Receivables include electronically recorded monetary claims (in years they are disclosed); inventories and payables are measured against cost of sales.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 期末残高ベースのため決算日の季節性が混じる。売上債権は電子記録債権を含み(開示された年)、棚卸資産・仕入債務は売上原価ベース。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑧ ROIC · ROE · ROA — 자본에서 얼마를 버나ROIC · ROE · ROA — how much is earned on capitalROIC・ROE・ROA — 資本からどれだけ稼ぐか

% · Data as of 2026-03-31 · Created 2026-11-01
ROIC(세후 영업이익 ÷ 영업 투하자본)는 FY2015 -1.3% · 고점 FY2021 14.1% · FY2025 6.1%. 영업 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유주식 포함) — 본업에 묶인 돈만 남긴다. ROE·ROA 는 기초·기말 평균 분모.ROIC (after-tax operating profit ÷ operating invested capital) was -1.3% in FY2015 · peak FY2021 14.1% · FY2025 6.1%. Operating invested capital = equity + interest-bearing debt − cash and short-term securities − investment securities (including cross-shareholdings) — leaving only the money tied up in the core business. ROE and ROA use the average of opening and closing balances as the denominator.ROIC(税引後営業利益 ÷ 営業投下資本)はFY2015 -1.3% · ピークFY2021 14.1% · FY2025 6.1%。 営業投下資本 = 自己資本 + 有利子負債 − 現金・短期有価証券 − 投資有価証券(政策保有株式を含む)— 本業に拘束されたお金だけを残す。ROE・ROAは期首・期末の平均を分母とする。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 영업 투하자본에서 투자유가증권(정책보유 포함)을 뺐다 · 세율은 그해 실효세율 · 기초·기말 평균 분모라 첫 해는 기말만.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Investment securities (including cross-shareholdings) are excluded from operating invested capital · the tax rate is that year's effective rate · denominators average opening and closing balances, so the first year uses the closing balance only.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 営業投下資本から投資有価証券(政策保有株式を含む)を除いた · 税率はその年の実効税率 · 分母は期首・期末の平均のため、初年度は期末のみ。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑨ 자본 배분 — FY2015~FY2025 누적, 돈은 어디로 갔나Capital allocation — cumulative FY2015~FY2025: where did the money go資本配分 — FY2015~FY2025累計、お金はどこへ行ったか

억엔 · 현금흐름표 누계JPY 100mn · cumulative cash-flow statement億円 · キャッシュ・フロー計算書の累計 · Data as of 2026-03-31 · Created 2026-11-01
영업현금흐름Operating cash flow営業キャッシュ・フロー20,553억엔20,553 JPY 100mn20,553億円
설비투자Capex設備投資10,447억엔10,447 JPY 100mn10,447億円
주주환원(배당 + 자사주)Shareholder returns (dividends + buybacks)株主還元(配当 + 自社株買い)6,466억엔6,466 JPY 100mn6,466億円
투자주식 매각 대금Proceeds from selling investment securities投資有価証券の売却収入582억엔582 JPY 100mn582億円
순현금 변화(기말 − 기초)Change in net cash (closing − opening)ネットキャッシュの増減(期末 − 期首)-3,615억엔-3,615 JPY 100mn-3,615億円
FCF 10,105억엔 vs 주주환원 6,466억엔 — 환원은 FCF 안에서 했다. 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.FCF 10,105 JPY 100mn vs shareholder returns 6,466 JPY 100mn — returns were made within FCF. 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.FCF 10,105億円 vs 株主還元6,466億円 — 還元はFCFの範囲内で行った。 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 현금흐름표 누계 — 연결 범위 변경·환율 효과·기타 재무 항목은 따로 싣지 않았다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Cumulative cash-flow-statement figures — changes in the scope of consolidation, FX effects and other financing items are not shown separately.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: キャッシュ・フロー計算書の累計 — 連結範囲の変更・為替の影響・その他の財務項目は個別に載せていない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑩ 특별손익 — 본업 밖 이익이 얼마나 받치나Extraordinary items — how much non-core profit props up earnings特別損益 — 本業以外の利益がどれだけ支えているか

억엔JPY 100mn億円 · Data as of 2026-03-31 · Created 2026-11-01
FY특별이익Extraordinary gains特別利益투자주식 매각익Gains on sale of investment securities投資有価証券売却益특별손실Extraordinary losses特別損失감손Impairment減損특별손익 ÷ 세전이익Extraordinary items ÷ pre-tax profit特別損益 ÷ 税引前利益
201595.70.4426.3 355.960.2%
201628.713.2198.3 109.0-13.8%
2017143.04.1284.5 87.3-6.7%
2018115.53.6359.7 158.8-16.9%
2019229.45.0261.9 90.418.9%
2020150.90.6588.8 201.6-67.8%
2021266.835.5979.0 159.1-18.4%
2022756.65.9489.1 258.27.7%
2023154.237.5739.2 106.2-17.9%
2024130.90.7695.0 272.2-35.6%
2025275.326.0350.4 181.0-3.4%
FY2015~FY2025 투자주식 매각익 누계 132억엔 = 누적 순이익 13,455억엔의 1.0%(세전 기준이라 상한). 최근 3년 특별손익 ÷ 세전이익 평균 -19.0%.Cumulative gains on sale of investment securities FY2015~FY2025: 132 JPY 100mn = 1.0% of cumulative net profit of 13,455 JPY 100mn (pre-tax basis, so an upper bound). Average extraordinary items ÷ pre-tax profit over the last 3 years: -19.0%.FY2015~FY2025の投資有価証券売却益の累計132億円 = 累計純利益13,455億円の1.0%(税引前ベースのため上限)。直近3年の特別損益 ÷ 税引前利益の平均-19.0%。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 특별손익은 일본기준 손익계산서 구분 그대로 · 특별 제외 순이익은 그해 실효세율로 세후 환산한 근사.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Extraordinary items follow the Japan GAAP income-statement classification · net profit excluding extraordinary items is an approximation converted to after-tax at that year's effective tax rate.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 特別損益は日本基準の損益計算書の区分のまま · 特別損益除く純利益はその年の実効税率で税引後に換算した近似。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑪ 장부 점검 게이지 — 5개 플래그Accounting check gauges — 5 flags帳簿点検ゲージ — 5個のフラグ

빨강 2 · 주황 1 · 최근 연도 기준Red 2 · amber 1 · latest year赤2 · 橙1 · 直近年度ベース · Data as of 2026-03-31 · Created 2026-11-01
이익−현금 괴리(발생액/총자산, 3년 평균)Profit–cash gap (accruals/total assets, 3-year average)利益と現金の乖離(発生高/総資産、3年平均)
-5.0%-5.0%-5.0% · 기준 5%· threshold 5%· 基準5%
순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).
매출채권 증가 − 매출 증가(최근 연도)Receivables growth − revenue growth (latest year)売上債権の増加 − 売上高の増加(直近年度)
14.8%14.8%14.8% · 기준 10%· threshold 10%· 基準10%
채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.
재고 증가 − 매출 증가(최근 연도)Inventory growth − revenue growth (latest year)棚卸資産の増加 − 売上高の増加(直近年度)
20.4%20.4%20.4% · 기준 10%· threshold 10%· 基準10%
재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).
특별손익 ÷ 세전이익(3년 평균)Extraordinary items ÷ pre-tax profit (3-year average)特別損益 ÷ 税引前利益(3年平均)
-19.0%-19.0%-19.0% · 기준 20%· threshold 20%· 基準20%
투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.
설비투자 ÷ 감가상각(3년) vs 매출 연성장Capex ÷ depreciation (3 years) vs annual revenue growth設備投資 ÷ 減価償却費(3年)vs 売上高の年成長率
1.17배1.17x1.17倍 · 기준 2.0배· threshold 2.0x· 基準2.0倍
상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 -5.0%.상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 -5.0%.상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 -5.0%.

⑫ 밸류에이션 — P/B · P/E · EV/EBITDAValuation — P/B · P/E · EV/EBITDAバリュエーション — P/B・P/E・EV/EBITDA

배 · 기말 주가는 가공값x · year-end prices are derived values倍 · 期末株価は加工値 · Data as of 2026-03-31 · Created 2026-11-01
FY시가총액(억엔)Market cap (JPY 100mn)時価総額(億円)P/BP/EEV/EBITDA배당수익률Dividend yield配当利回りFCF 수익률FCF yieldFCF利回り순현금 ÷ 시총Net cash ÷ market capネットキャッシュ ÷ 時価総額투자유가증권 ÷ 시총Investment securities ÷ market cap投資有価証券 ÷ 時価総額
2015——— ——%—% —%—%
20166,1721.067.0 7.71.30%1.6% -155.4%67.2%
20178,4360.974.8 6.11.97%9.2% -95.3%50.1%
20187,2920.879.2 6.62.71%9.6% -117.7%55.0%
2019——— ——%—% —%—%
20208,4860.7424.3 8.44.20%4.4% -135.3%28.2%
202110,0620.713.6 4.15.02%3.8% -118.9%25.9%
20228,5010.533.4 5.74.14%-14.5% -159.1%28.8%
202314,4600.806.5 5.83.05%20.8% -80.2%18.4%
202412,8670.7513.5 9.03.43%29.6% -80.1%23.8%
202518,8120.9811.0 9.82.33%12.0% -61.1%18.1%
시가총액 = 기말 주가(가공) × (발행주식 − 자기주식). EV = 시가총액 + 이자부채(리스 포함) − 현금·단기유가증권. 투자유가증권(정책보유 포함)은 EV 에서 빼지 않았다 — 표의 마지막 열이 그 크기다.Market cap = year-end price (derived) × (shares issued − treasury shares). EV = market cap + interest-bearing debt (including leases) − cash and short-term securities. Investment securities (including cross-shareholdings) are not deducted from EV — the last column of the table shows their size.時価総額 = 期末株価(加工値)×(発行済株式数 − 自己株式数)。EV = 時価総額 + 有利子負債(リースを含む)− 現金・短期有価証券。投資有価証券(政策保有株式を含む)はEVから差し引いていない — 表の最終列がその大きさだ。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 기말 주가는 그해 有報의 EPS × PER 로 역산한 가공값 — 시장 주가 원천을 쓰지 않았다. 적자 해는 PER 미기재로 빈칸.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Year-end share prices are derived values back-calculated as EPS × P/E from that year's annual securities report — no market price source is used. Loss years are blank because P/E is not reported.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 期末株価はその年の有報のEPS × PERから逆算した加工値 — 市場の株価データは使っていない。赤字の年はPER記載なしのため空欄。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑬ P/E 냐 P/B 냐 — 이 주가는 무엇을 따라가나P/E or P/B — what does this share price track?P/EかP/Bか — この株価は何に連動するか

有報 5년 표 FY2012~FY20255-year tables in the annual securities reports FY2012~FY2025有報の5年表 FY2012~FY2025 · Data as of 2026-03-31 · Created 2026-11-01
이 종목 · 그해 이익 기준This stock · same-year earningsこの銘柄 · その年の利益ベース
β 0.14
log(P/B) 를 log(ROE) 에 회귀한 기울기(±0.15, 11년). 1 이면 ROE 가 변해도 P/E 가 그대로(이익을 따라감), 0 이면 P/B 가 그대로(장부에 묶임). → P/B 에 묶여 있다.Slope from regressing log(P/B) on log(ROE) (±0.15, 11 years). 1 means P/E stays put as ROE changes (tracks earnings); 0 means P/B stays put (anchored to book). → anchored to P/B.log(P/B)をlog(ROE)に回帰した傾き(±0.15、11年)。1ならROEが変わってもP/Eは不変(利益に連動)、0ならP/Bが不変(簿価に縛られる)。→ P/Bに縛られている。
이 종목 · 3년 평균 이익 기준This stock · 3-year average earningsこの銘柄 · 3年平均利益ベース
β 0.00
일시 이익은 주가에 안 실린다(일회성이면 P/E 가 반대로 움직인다). 3년 평균 EPS 로 바꿔 다시 잰 값(±0.17, 8년) → 평탄화 이익으로 봐도 P/B 에 묶여 있다.One-off profits are not priced in (if a profit is one-off, P/E moves the other way). Re-measured with 3-year average EPS (±0.17, 8 years) → still anchored to P/B on smoothed earnings.一時的な利益は株価に織り込まれない(一過性ならP/Eが逆に動く)。3年平均EPSに替えて測り直した値(±0.17、8年) → 平準化利益で見てもP/Bに縛られている。
P/B 변화 분해 FY2012→FY2025Decomposition of P/B change FY2012→FY2025P/B変化の分解 FY2012→FY2025
+68%
log(P/B) 변화 = log(ROE) +15% + log(P/E) +53%. P/B 범위 0.48~1.06배 · 표준편차(log) P/E 0.58 vs P/B 0.28.Change in log(P/B) = log(ROE) +15% + log(P/E) +53%. P/B range 0.48~1.06x · standard deviation (log) P/E 0.58 vs P/B 0.28.log(P/B)の変化 = log(ROE) +15% + log(P/E) +53%。P/Bの範囲0.48~1.06倍 · 標準偏差(log)P/E 0.58 vs P/B 0.28。
일본 시장 표본 369사 · 회사 안 시계열Japan market sample, 369 companies · within-company time series日本市場の標本369社 · 企業内の時系列
β 0.15
같은 회귀를 369사(3443개 회사-연도)에 — 3년 평균 이익 기준 β 0.18. 회사별 β 중앙값 0.22. 그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.The same regression across 369 companies (3443 company-years) — β on 3-year average earnings 0.18. Median company β 0.22. 그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.同じ回帰を369社(3443の企業・年度)に — 3年平均利益ベースのβ 0.18。企業別βの中央値0.22。그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.
점 하나 = 한 해(그해 ROE = EPS ÷ BPS, P/B = PER × EPS ÷ BPS — 둘 다 같은 有報 5년 표의 같은 주식 기준이라 분할·병합에 무관). 적자 해는 PER 이 비어 빠진다(3년).Each dot = one year (ROE that year = EPS ÷ BPS, P/B = P/E × EPS ÷ BPS — both on the same share basis from the same 5-year table in the annual securities report, so unaffected by splits and consolidations). Loss years have no P/E and are excluded (3 years).点1つ = 1年(その年のROE = EPS ÷ BPS、P/B = PER × EPS ÷ BPS — どちらも同じ有報5年表の同じ株式ベースのため、分割・併合の影響を受けない)。赤字の年はPERが空欄のため除外(3年)。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 한 회사의 연간 관측이라 표본이 작다(표준오차를 함께 적었다) · 적자 해는 빠진다 · 평탄화 이익은 그해 포함 직전 연도들의 EPS/BPS 평균.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Annual observations of a single company, so the sample is small (standard errors are shown alongside) · loss years are excluded · smoothed earnings are the average EPS/BPS of the preceding years including that year.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の出光興産株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 1社の年次観測のため標本が小さい(標準誤差を併記した)· 赤字の年は除外 · 平準化利益はその年を含む直近数年のEPS/BPSの平均。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑭ 측정 한계Measurement limitations測定の限界

1고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.
22024-04 四半期報告書 폐지 → 2024년 하반기부터는 반기만 있다. 4분기 편중·분기 회귀는 그 전 기간만.2024-04 四半期報告書 폐지 → 2024년 하반기부터는 반기만 있다. 4분기 편중·분기 회귀는 그 전 기간만.2024-04 四半期報告書 폐지 → 2024년 하반기부터는 반기만 있다. 4분기 편중·분기 회귀는 그 전 기간만.
3기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.
4ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).

같이 볼 페이지Related pages併せて見るページ